Literature DB >> 17380255

Low-dose oral vitamin K to normalize the international normalized ratio prior to surgery in patients who require temporary interruption of warfarin.

Karen Woods1, James D Douketis, Kala Kathirgamanathan, Qilong Yi, Mark A Crowther.   

Abstract

BACKGROUND: In patients who require warfarin interruption before surgery and have an elevated international normalized ratio (INR) before surgery, low-dose vitamin K may normalize the INR in time for surgery. PATIENTS AND METHODS: In a retrospective cohort study, we assessed the efficacy of 1 mg oral vitamin K to normalize the INR for surgery and whether resistance to re-anticoagulation occurs when warfarin is restarted after surgery. We studied a cohort of patients with an INR 1.4-1.9 on the day before surgery who received 1 mg oral vitamin K (vitamin K group), and a comparator group of patients with a normal INR (< or = 1.3) on the day before surgery who did not receive vitamin K (no vitamin K group). In both patient groups, we determined the proportion of patients with a normalized INR on the day of surgery and compared the mean INR after surgery when warfarin was resumed.
RESULTS: Of 43 patients in the vitamin K group, the INR was normalized (< or = 1.3) in 33 patients (76.6; 95% confidence interval [CI]: 64.1-89.4), and the INR was normal or near-normal (< or = 1.4) in 39 patients (90.7; 95% CI: 82.0-99.4) on the day of surgery. The mean (standard deviation) INR in the vitamin K and no vitamin K group 4-8 days after surgery was 1.75 (0.34) and 1.59 (0.36), respectively (P = 0.56).
CONCLUSIONS: In patients requiring interruption of warfarin for surgery, 1 mg oral vitamin K on the day before surgery can normalize the INR by the day of surgery and may not confer resistance to warfarin re-anticoagulation after surgery.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17380255     DOI: 10.1007/s11239-007-0022-z

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  9 in total

1.  Living with prosthetic heart valves. Subsequent noncardiac operations and the risk of thromboembolism or hemorrhage.

Authors:  R E Katholi; S P Nolan; L B McGuire
Journal:  Am Heart J       Date:  1976-08       Impact factor: 4.749

Review 2.  Perioperative bridging interruption with heparin for the patient receiving long-term anticoagulation.

Authors:  Alex C Spyropoulos; Alexander G G Turpie
Journal:  Curr Opin Pulm Med       Date:  2005-09       Impact factor: 3.155

Review 3.  Perioperative anticoagulation management in patients who are receiving oral anticoagulant therapy: a practical guide for clinicians.

Authors:  James D Douketis
Journal:  Thromb Res       Date:  2002-10-01       Impact factor: 3.944

4.  Randomized, placebo-controlled trial of oral phytonadione for excessive anticoagulation.

Authors:  R J Patel; D M Witt; J J Saseen; D J Tillman; D S Wilkinson
Journal:  Pharmacotherapy       Date:  2000-10       Impact factor: 4.705

5.  Reversal of excessive effect of regular anticoagulation: low oral dose of phytonadione (vitamin K1) compared with warfarin discontinuation.

Authors:  V Pengo; A Banzato; E Garelli; A Zasso; A Biasiolo
Journal:  Blood Coagul Fibrinolysis       Date:  1993-10       Impact factor: 1.276

Review 6.  When patients on warfarin need surgery.

Authors:  Amir K Jaffer; Daniel J Brotman; Nkem Chukwumerije
Journal:  Cleve Clin J Med       Date:  2003-11       Impact factor: 2.321

7.  Discontinuing anticoagulant therapy in surgical patients with cardiac valve prostheses. Observations in 180 operations.

Authors:  J H Tinker; S Tarhan
Journal:  JAMA       Date:  1978-02-20       Impact factor: 56.272

8.  Low-dose oral vitamin K reliably reverses over-anticoagulation due to warfarin.

Authors:  M A Crowther; D Donovan; L Harrison; J McGinnis; J Ginsberg
Journal:  Thromb Haemost       Date:  1998-06       Impact factor: 5.249

9.  Temporary discontinuation of warfarin therapy: changes in the international normalized ratio.

Authors:  R H White; T McKittrick; R Hutchinson; J Twitchell
Journal:  Ann Intern Med       Date:  1995-01-01       Impact factor: 25.391

  9 in total
  9 in total

1.  Peri-operative antithrombotic therapy: bridging the gap.

Authors:  A Thapar; H Moore; D Golden; Ah Davies
Journal:  Ann R Coll Surg Engl       Date:  2012-04       Impact factor: 1.891

2.  Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  James D Douketis; Alex C Spyropoulos; Frederick A Spencer; Michael Mayr; Amir K Jaffer; Mark H Eckman; Andrew S Dunn; Regina Kunz
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

3.  The effect of preoperative vitamin K on the INR in bridging therapy.

Authors:  Ashrei Bayewitz; Barbara Scorziello; Clarice Maala; Emily Giannattasio; Henny Heisler Billett
Journal:  Int J Hematol       Date:  2015-01-31       Impact factor: 2.490

Review 4.  Management of oral antiplatelet agents and anticoagulation therapy before bronchoscopy.

Authors:  Houssein A Youness; Jean Keddissi; Ilya Berim; Ahmed Awab
Journal:  J Thorac Dis       Date:  2017-09       Impact factor: 2.895

Review 5.  Safety of Anticoagulation Interruption in Patients Undergoing Surgery or Invasive Procedures: A Systematic Review and Meta-analyses of Randomized Controlled Trials and Non-randomized Studies.

Authors:  Frédérique Hovaguimian; Sabrina Köppel; Donat R Spahn
Journal:  World J Surg       Date:  2017-10       Impact factor: 3.352

Review 6.  Perioperative management of patients on chronic antithrombotic therapy.

Authors:  Thomas L Ortel
Journal:  Blood       Date:  2012-08-01       Impact factor: 22.113

7.  Budget impact analysis of warfarin reversal therapies among hip fracture patients in Finland.

Authors:  Timo Purmonen; Soili Törmälehto; Niina Säävuori; Hannu Kokki
Journal:  Drugs R D       Date:  2015-03

Review 8.  Management of antithrombotic therapy during cardiac implantable device surgery.

Authors:  Ahmed AlTurki; Riccardo Proietti; David H Birnie; Vidal Essebag
Journal:  J Arrhythm       Date:  2016-01-18

9.  An evidence-based warfarin management protocol reduces surgical delay in hip fracture patients.

Authors:  I Ahmed; M A Khan; V Nayak; A Mohsen
Journal:  J Orthop Traumatol       Date:  2013-11-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.